Sustaining progress: Creating US policies to spur global health innovation

Sustaining progress: Creating US policies to spur global health innovation, February 2012

  • “The United States has long played a critical role in driving innovation for the world’s neglected diseases, including HIV/AIDS, malaria, TB, NTDs, and childhood killers like pneumonia and diarrheal diseases. These diseases disproportionately impact people living in low-income countries, although some also affect populations in the United States and are resurging. And while the tools needed to test, treat, and prevent neglected diseases are getting better, in many cases, adequate drugs, vaccines, and diagnostics are simply not available. For instance, the world still does not have a vaccine for HIV, and the vaccine for TB is almost 100 years old and ineffective in preventing the most infectious form of the disease for most populations. Many treatments and diagnostics for NTDs such as visceral leishmaniasis, sleeping sickness, schistosomiasis, and Chagas are painful, expensive, and ineffective. And children in low-income countries still die every day from diarrhea, pneumonia, and other diseases that are preventable and treatable in the United States.”
    • LinkedIn
    Posted in: Government Documents
    ➤